Rome, Italy

Frank Narjes

This inventor holds 19 USPTO granted patents and 6 EPO patents, primarily in Antiviral Compounds. Top assignees: Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa, Merck Sharp + Dohme Corp., Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.p.a.. Active years: 2005-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Narjes. Retrieved from https://idiyas.com/inventor/frank-narjes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 47.4

 

Average Co-Inventor Count = 6.2

ph-index = 7

Forward Citations = 333(Granted Patents)


Location History:

  • Ariccia, IT (2005 - 2010)
  • Pomezia, IT (2006 - 2011)
  • Arccia, IT (2011)
  • Rome, IT (2006 - 2012)
  • Kullavik, SE (2016 - 2017)

Company Filing History:


Years Active: 2005-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Benzofuran Compounds
Tetracyclic Indoles
Nucleoside Phosphoramidates
Antiviral Agents
Heterocyclic Derivatives
Viral Infections
Thienopyrroles
Peptide Inhibitors
Hepatitis C Virus
RNA-dependent RNA Virus
Polymerase Inhibitors
Indole Derivatives
19 patents (USPTO):Explore Patents

Title: Frank Narjes: A Trailblazer in Innovation and Invention

Introduction:

Frank Narjes is a distinguished inventor who continues to inspire the next generation of inventors with his unwavering passion for innovation and relentless pursuit of excellence. Hailing from Rome, Italy, he has left an undeniable impact on the world of inventions, and his legacy is set to endure for years to come.

Latest Patents:

Frank Narjes holds an impressive total of 19 patents, with his latest groundbreaking inventions revolving around substituted benzofuran compounds and their methods of use for the treatment of viral diseases, especially hepatitis C virus (HCV) infections. These compounds are designed as potent HCV NS5B polymerase inhibitors, showcasing his expertise in combating challenging health issues.

Career Highlights:

Throughout his career, Frank Narjes has contributed his inventive flair to renowned companies such as Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa and Merck Sharp & Dohme Corporation. His innovative spirit and dedication to pushing the boundaries of science have made him a sought-after expert in the field of pharmaceutical research and development.

Collaborations:

Frank Narjes has collaborated with esteemed professionals in the industry, including Joerg Habermann and Ian Stansfield. Together, they have worked on various projects that have furthered the advancement of medical science and brought about novel solutions to complex viral diseases.

Conclusion:

In conclusion, Frank Narjes stands as a shining example of an inventor who has not only made significant contributions to the world of inventions but has also paved the way for future innovators. His pioneering work in developing compounds for the treatment of viral diseases underscores his commitment to improving global health outcomes. As we look towards the future, Frank Narjes' legacy will undoubtedly continue to inspire generations of inventors to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…